tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Inventiva SA (FR:IVA)
:IVA
France Market
IVA
Inventiva
RESEARCH TOOLSreports
Advertisement

Inventiva (IVA) Stock News & Sentiment

Compare
13 Followers
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
24d ago
IVA
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
Premium
Ratings
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
1M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
2M ago
IVA
Inventiva’s Strategic Positioning and Promising Developments Drive Buy Rating
Premium
Ratings
Inventiva’s Strategic Positioning and Promising Developments Drive Buy Rating
3M ago
IVA
Inventiva’s Strong Financial Position and Promising Phase 3 Trial Drive Buy Rating
Premium
Ratings
Inventiva’s Strong Financial Position and Promising Phase 3 Trial Drive Buy Rating
3M ago
IVA
Inventiva’s Lanifibranor: A Promising Investment in the MASH Space with Strong Phase III Progress and Financial Backing
Premium
Ratings
Inventiva’s Lanifibranor: A Promising Investment in the MASH Space with Strong Phase III Progress and Financial Backing
5M ago
IVA
Inventiva’s Strategic Milestones and Promising Outlook Drive Buy Rating
Premium
Ratings
Inventiva’s Strategic Milestones and Promising Outlook Drive Buy Rating
7M ago
IVA
More FR:IVA News >

IVA News on the Web

The Price Is Right For Inventiva S.A. (EPA:IVA) Even After Diving 30%
Simply Wall St
Neutral
Revenue Downgrade: Here's What Analysts Forecast For Inventiva S.A. (EPA:IVA)
Simply Wall St
Neutral
Canaccord Genuity Reaffirms Their Buy Rating on Inventiva (IVA)
TipRanks News
Neutral
Need To Know: The Consensus Just Cut Its Inventiva S.A. (EPA:IVA) Estimates For 2025
Simply Wall St
Bearish
Here are Wednesday's biggest analyst calls: Nvidia, Apple, Ralph Lauren, DoorDash, CoreWeave, Krispy Kreme & more
CNBC
Neutral
There's Reason For Concern Over Inventiva S.A.'s (EPA:IVA) Massive 27% Price Jump
Simply Wall St
Neutral
TD Cowen Sticks to Its Buy Rating for Inventiva (0RNK)
TipRanks News
Neutral
Inventiva Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St
Neutral

News Score - Last 7 Days

Neutral
FR:IVA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:IVA’s Media Buzz Sentiment?
1 articles about FR:IVA were published this week. In an average week, 1 articles are published.
    What is FR:IVA’s weekly average amount of articles?
    In an average week, 1 articles about FR:IVA are published.
      What is FR:IVA’s News Sentiment?
      50% of articles about FR:IVA were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        RNAAvidity Biosciences
        AVTRAvantor
        HCAHCA Healthcare
        SLPSimulations Plus
        CICigna
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing